Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Bauer

Showing results (61-70 of 240) with videos related to

Pageof 24
Sort By:
Molecules (Basel, Switzerland)|October 17, 2018
Role of Extracellular Loops and Membrane Lipids for Ligand Recognition in the Neuronal Adenosine Receptor Type 2A: An Enhanced Sampling Simulation StudyRuyin Cao, Alejandro Giorgetti, Andreas Bauer, et al.
Preventive Medicine|February 25, 2026
Quantifying and visualising heterogeneity in cumulative adverse childhood experiences scores: A national survey of US childrenBruna Cardone Pedroso Elorza, Alicia Matijasevich, Maria Fernanda Tourinho Peres, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2012
Caffeine occupancy of human cerebral A1 adenosine receptors: in vivo quantification with 18F-CPFPX and PETDavid Elmenhorst, Philipp T Meyer, Andreas Matusch, et al.
Pharmaceuticals (Basel, Switzerland)|April 25, 2019
Relevance of In Vitro Metabolism Models to PET Radiotracer Development: Prediction of In Vivo Clearance in Rats from Microsomal Stability DataDaniela Schneider, Angela Oskamp, Marcus Holschbach, et al.
Neuroscience and Biobehavioral Reviews|April 3, 2022
Neural correlates of affective control regions induced by common therapeutic strategies in major depressive disorders: An activation likelihood estimation meta-analysis studyChanghong Li, Quanling Hu, Delong Zhang, et al.
European Journal of Medical Research|March 27, 2021
EuroScore and IL-6 predict the course in ICU after cardiac surgeryAndreas Bauer, Insa Korten, Gerd Juchem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2013
In vivo kinetic and steady-state quantification of 18F-CPFPX binding to rat cerebral A1 adenosine receptors: validation by displacement and autoradiographic experimentsDavid Elmenhorst, Tina Kroll, Franziska Wedekind, et al.
Nuclear Medicine and Biology|December 16, 2019
Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A<sub>1</sub> adenosine receptorDaniela Schneider, Angela Oskamp, Marcus Holschbach, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2018
Cognitive impairments by alcohol and sleep deprivation indicate trait characteristics and a potential role for adenosine A<sub>1</sub> receptorsEva-Maria Elmenhorst, David Elmenhorst, Sibylle Benderoth, et al.
Neuroimage|June 30, 2006
A1 adenosine receptor PET using [18F]CPFPX: displacement studies in humansPhilipp T Meyer, David Elmenhorst, Andreas Matusch, et al.
Pageof 24

Showing results (61-70 of 240) with videos related to

Sort By:
Pageof 24
Molecules (Basel, Switzerland)|October 17, 2018
Role of Extracellular Loops and Membrane Lipids for Ligand Recognition in the Neuronal Adenosine Receptor Type 2A: An Enhanced Sampling Simulation StudyRuyin Cao, Alejandro Giorgetti, Andreas Bauer, et al.
Preventive Medicine|February 25, 2026
Quantifying and visualising heterogeneity in cumulative adverse childhood experiences scores: A national survey of US childrenBruna Cardone Pedroso Elorza, Alicia Matijasevich, Maria Fernanda Tourinho Peres, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2012
Caffeine occupancy of human cerebral A1 adenosine receptors: in vivo quantification with 18F-CPFPX and PETDavid Elmenhorst, Philipp T Meyer, Andreas Matusch, et al.
Pharmaceuticals (Basel, Switzerland)|April 25, 2019
Relevance of In Vitro Metabolism Models to PET Radiotracer Development: Prediction of In Vivo Clearance in Rats from Microsomal Stability DataDaniela Schneider, Angela Oskamp, Marcus Holschbach, et al.
Neuroscience and Biobehavioral Reviews|April 3, 2022
Neural correlates of affective control regions induced by common therapeutic strategies in major depressive disorders: An activation likelihood estimation meta-analysis studyChanghong Li, Quanling Hu, Delong Zhang, et al.
European Journal of Medical Research|March 27, 2021
EuroScore and IL-6 predict the course in ICU after cardiac surgeryAndreas Bauer, Insa Korten, Gerd Juchem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2013
In vivo kinetic and steady-state quantification of 18F-CPFPX binding to rat cerebral A1 adenosine receptors: validation by displacement and autoradiographic experimentsDavid Elmenhorst, Tina Kroll, Franziska Wedekind, et al.
Nuclear Medicine and Biology|December 16, 2019
Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A<sub>1</sub> adenosine receptorDaniela Schneider, Angela Oskamp, Marcus Holschbach, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2018
Cognitive impairments by alcohol and sleep deprivation indicate trait characteristics and a potential role for adenosine A<sub>1</sub> receptorsEva-Maria Elmenhorst, David Elmenhorst, Sibylle Benderoth, et al.
Neuroimage|June 30, 2006
A1 adenosine receptor PET using [18F]CPFPX: displacement studies in humansPhilipp T Meyer, David Elmenhorst, Andreas Matusch, et al.
Pageof 24